Main Page
Deanship
The Dean
Dean's Word
Curriculum Vitae
Contact the Dean
Vision and Mission
Organizational Structure
Vice- Deanship
Vice- Dean
KAU Graduate Studies
Research Services & Courses
Research Services Unit
Important Research for Society
Deanship's Services
FAQs
Research
Staff Directory
Files
Favorite Websites
Deanship Access Map
Graduate Studies Awards
Deanship's Staff
Staff Directory
Files
Researches
Contact us
عربي
English
About
Admission
Academic
Research and Innovations
University Life
E-Services
Search
Deanship of Graduate Studies
Document Details
Document Type
:
Thesis
Document Title
:
EFFECT OF DICLOFENAC ON DOXORUBICIN-INDUCED APOPTOSIS IN BREAST CANCER CELLS
تأثير عقارالدكلوفيناك على موت الخلايا ا المبرمج الذي يحدثه الدوكسوروبيسين في خلايا سرطان الثدي
Subject
:
Faculty of medicine
Document Language
:
Arabic
Abstract
:
Background: Breast cancer is the most common disease in women worldwide. Doxorubicin (DOX) is a chemotherapeutic drug from anthracycline family and is highly effective in advanced breast cancer. Unfortunately, DOX may lead to severe heart damage. Many strategies have been investigated to protect the heart against DOX induced cardiotoxicity. Recent studies evaluated the effect of diclofenac (DICLO)as an anti-cancer. Therefore, the current study aimed to investigate the potential chemo sensitizing effect of Diclofenac on DOX cytotoxicity on MCF-7 as well as elucidating the possible underlying mechanism. Materials and methods: Evaluate the effect of DOX on apoptosis induction, cell cycle phase distribution, cellular absorption, and p-glycoprotein activity in breast cancer cells when DICLO was present with different concentrations. Results: The addition of DICLO (10 and 100 µg / ml) increased the effectiveness of DOX as it led to a significant decrease in IC50 compared to the cells treated with DOX alone. Cell cycle analysis showed that DICLO (100µg / ml) significantly increased the percentage of apoptotic phase cells in DOX (0.25 µg / ml) from 3.5% to 10.9%.In addition, significantly increased apoptotic phase cells to 40.2%when DICLO added to DOX(1 µg / ml) compared to 15.6% in DOX alone. Programmed cell death test showed that combined treatment of DICLO with DOX resulted in a significant increase in the rate of early programmed cell death to more than 12 times and three times greater than DOX(0.25 µg / ml and 1µg / ml) respectively. DICLO increased the cellular absorption of DOX significantly by 32% and 63% compared to DOX alone (5 µg/ ml and 10 ug/ml) respectively. The addition of 100 μg/mL diclofenac 10 μg/mL DOX re Conclusion: The present study concluded that DICLO potentiates the cytotoxic activity of DOX against the growth of MCF-7 cancer cells through induction of apoptosis, inhibition of p-glycoprotein activity and enhance DOX cellular uptake.
Supervisor
:
Prof. Abdel-Moneim M. Osman
Thesis Type
:
Master Thesis
Publishing Year
:
1442 AH
2021 AD
Co-Supervisor
:
Dr. FatemahOmar Kamel
Added Date
:
Monday, June 7, 2021
Researchers
Researcher Name (Arabic)
Researcher Name (English)
Researcher Type
Dr Grade
Email
نهي الديب محمد
Mohammed, Noha Al-Deeb
Researcher
Master
Files
File Name
Type
Description
47037.pdf
pdf
Back To Researches Page